MISX
DIOD
Market cap9mUSD
Oct 20, Last price
8.35RUB
1D
-2.92%
1Q
-34.48%
Jan 2017
103.99%
IPO
-50.74%
Name
DIOD PAO
Chart & performance
P/E
—
P/S
1.47
EPS
—
Vol. 1Y
45.22%
Shs. 5Y
-1.26%
Rev. 5Y
0.17%
Div Yld LY
10.06%
Div Yld TTM
3.59%
Revenues
521m
+77.02%
Net income
-71m
L
CFO
60m
-41.56%
Dividend
Jul 06, 20260.3 RUB/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
DIOD Maker of Eco-Friendly Equipment & Nutrition OJSC engages in the manufacturing of pharmaceuticals and consumer healthcare products. Its products include food supplements, bio active cosmetics, electrometrical equipment, and pharmaceutical. It is also involved in the development and production of innovative medicines based on natural raw materials, dietary supplements, skin care products, and medical equipment. The company was founded by Kozlov Vladimir Alexandrovich and Tikhonov Vladimir Petrovich on February 16, 1994 and is headquartered in Moscow, Russia.
Key people
Alla Kudeyarova
Independent Director, Chief Accountant · since 2015
Andrey Chemeris
Independent Director, Deputy General Director of Finance
Alfiya Yunisova
Independent Director, Senior Manager of Foreign Trade Activities
Eduard Chernyshkov
Director, Member of the Management Board, Director of Foreign Economic Relations
Vladimir Kozlov
Chairman of the Board, Member of the Management Board, First Deputy General Director · since 2019
Elena Nikolaeva
Director · since 2019
Vladimir Tikhonov
Director, General Director (CEO) - Chairman of the Management Board
Anton Belonozhkin
Independent Director · since 2018
Olga Chichkova
Independent Director
Dmitry Shmatkov
Independent Director · since 2018
Vadim Silantev
Independent Director
Yakov Yukelson
Independent Director · since 2016
Valuation
Title RUB in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||